OVERWEIGHT AND OBESE ADULTS
Clinical trials for OVERWEIGHT AND OBESE ADULTS explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT AND OBESE ADULTS trials appear
Sign up with your email to follow new studies for OVERWEIGHT AND OBESE ADULTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common vitamin stop liver scarring? new trial aims to find out
Disease control Recruiting nowThis phase 2 trial tests whether nicotinamide (a form of vitamin B3) can stop or reverse liver fibrosis in people with non-alcoholic fatty liver disease and obesity. Thirty adults will take either nicotinamide or a placebo daily for one year. Researchers will measure liver stiffn…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a smartphone app help people with obesity lose weight?
Disease control Recruiting nowThis pilot study tests a smartphone app called Eatit that provides a structured lifestyle program with support from a dietitian via video calls and messages. About 93 adults with obesity (BMI 30 or higher) will use the app for six months. Researchers will track changes in weight,…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: NA • Sponsor: Eatit AB • Aim: Disease control
Last updated Jun 26, 2026 19:18 UTC
-
New drug SYNT-101 tested for safety in first human trial
Knowledge-focused Recruiting nowThis early-phase study tests the safety and tolerability of a new drug called SYNT-101 in healthy adults and those who are overweight or have obesity. About 64 participants will receive either the drug or a placebo. The main goal is to check for side effects and how the drug move…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: PHASE1 • Sponsor: Syntis Bio • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC